ENDOLOGIX INC's ticker is ELGX and the CUSIP is 29266S106. A total of 135 filers reported holding ENDOLOGIX INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $576,000 | -44.1% | 804,212 | +49.0% | 0.00% | -33.3% |
| Q3 2018 | $1,031,000 | -47.7% | 539,759 | +55.1% | 0.00% | -50.0% |
| Q2 2018 | $1,970,000 | +515.6% | 348,109 | +482.0% | 0.01% | +500.0% |
| Q4 2017 | $320,000 | -20.0% | 59,811 | -33.4% | 0.00% | 0.0% |
| Q3 2017 | $400,000 | +59.4% | 89,771 | +73.7% | 0.00% | 0.0% |
| Q2 2017 | $251,000 | -54.1% | 51,671 | -45.9% | 0.00% | -50.0% |
| Q4 2016 | $547,000 | -75.1% | 95,565 | -45.8% | 0.00% | -77.8% |
| Q2 2016 | $2,198,000 | +46.2% | 176,400 | -1.9% | 0.01% | +28.6% |
| Q1 2016 | $1,503,000 | -15.4% | 179,732 | +55.2% | 0.01% | -12.5% |
| Q2 2015 | $1,776,000 | -48.9% | 115,791 | -41.9% | 0.01% | -57.9% |
| Q4 2013 | $3,476,000 | +37.1% | 199,267 | +26.8% | 0.02% | +18.8% |
| Q3 2013 | $2,535,000 | +119.7% | 157,152 | +80.9% | 0.02% | +100.0% |
| Q2 2013 | $1,154,000 | – | 86,856 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 1,121,447 | $2,142,000 | 1.45% |
| Essex Woodlands Management, Inc. | 1,257,468 | $6,684,000 | 1.39% |
| Camber Capital Management LP | 9,300,000 | $17,763,000 | 0.76% |
| PFM Health Sciences, LP | 7,408,585 | $14,150,000 | 0.21% |
| NEA Management Company, LLC | 2,490,204 | $4,756,000 | 0.20% |
| ArrowMark Colorado Holdings LLC | 10,276,145 | $19,627,000 | 0.16% |
| Brown Capital Management | 8,977,308 | $17,147,000 | 0.16% |
| Partner Investment Management, L.P. | 79,765 | $152,000 | 0.12% |
| ALTRINSIC GLOBAL ADVISORS LLC | 1,135,000 | $2,168,000 | 0.10% |
| Lombard Odier Asset Management (USA) Corp | 700,000 | $1,337,000 | 0.10% |